Within the plan
Your surgeon directs the recovery. What we do is added to that, with their knowledge.
Post-surgical recovery
After surgery, the plan is still your surgeon's
We support that recovery with adjunctive therapies, within the medical indication and never in place of it.
What it is and is not
An adjunct, not a substitute
Nothing we do replaces your surgeon's follow-up or the care plan they set. We coordinate with your treating team when appropriate, and if something is not indicated for your case, we say so.
Evaluation first
We review the procedure, your history, and contraindications before proposing anything.
Case by case
The indication depends on the surgery, not on a package someone bought.
Fase 01 de 04
01 · Inflammatory phase
Evolución tisular: 58%
Educational sequences
Visual context for four moments in the journey.
These pieces portray biological processes conceptually. They do not show a treatment outcome or replace evaluation by your surgeon or treating team.
Educational illustrations: they do not represent a patient, an individual indication, or a promise of healing or faster recovery.
FDA-cleared
Two cleared indications
These are the two situations in which the hyperbaric chamber holds FDA clearance. They are written as the evidence permits, without widening them. An uncomplicated orthopedic or bariatric surgery is neither of them; for that case, read the next section.
FDA-cleared
Chronic wounds
In selected patients with chronic wounds, it may help support healing as an adjunct to a physician-directed wound-care plan.
Compromised graft or flap
When a graft or flap is compromised, it may help support tissue oxygenation as an adjunctive medical therapy.
Where the evidence ends
What is still being studied
Hyperbaric oxygen is being studied to help support selected aspects of recovery after surgery; benefit depends on the procedure and the medical indication. It is not cleared as a category for post-surgical recovery in general.
We promise no faster recovery, no timeline for getting your life back, and no elimination of post-surgical inflammation.
Red light
For the scar and local inflammation
Photobiomodulation is used as an adjunctive therapy to support post-surgical tissue healing and reduce local inflammation.
Dose is part of the effect: it depends on the device, the wavelength, the distance, and the time. FDA 510(k) clearance is not FDA approval for every use.
How it starts
With an evaluation, not a package
We talk about your surgery
Which procedure, when, and what your surgeon told you.
We review the criteria
Contraindications, history, and whether any of our therapies applies to your case.
We coordinate when appropriate
When needed, we ask your permission to speak with your treating team.
We define the protocol
Pressure, dose, and number of sessions are set after that evaluation, never before.
How it is structured
Your surgeon receives nothing for referring you
You contract and pay Fenix directly. There is no cross-billing with the hospital or your surgeon, and no referral is compensated. The structure is deliberately built that way.
If your surgeon did not mention this, that says nothing about whether it helps. It says the decision is clinical, and it is made case by case, for your procedure.
Limits of the evidence
What you will not read here
- No promise of recovering faster after any surgery.
- No timeline for returning to activity, work, or sport.
- No claim that post-surgical inflammation is eliminated.
- No before-and-after, and no preview of your result.
Your story deserves context
Book an assessment and let’s discuss an appropriate next step for you.